AutoGenomics
Parte da empresa Prescient Medicine
Essa empresa é sua?
Visão geral da empresa AutoGenomics
1 escritórioLocalizações
AutoGenomics is mapping the road to the future of medicine. The company developed a genetic testing system called INFINITI that scans DNA samples for genetic disorders, infectious diseases, cancer, and pharmacogenetics (a patient's genetic likeliness to have an adverse reaction to a drug). AutoGenomics found about 25 uses for the INFINITI, but only four have been approved by the FDA for diagnostic use -- testing for sensitivity to the popular blood thinner warfarin, screening for the risk of developing cystic fibrosis or cervical cancer (for women with HPV), and testing for a gene that blocks common drugs from working. AutoGenomics was founded in 1999 as Neuron Technologies and applied to go public in 2008.
